JP2020503357A5 - - Google Patents

Download PDF

Info

Publication number
JP2020503357A5
JP2020503357A5 JP2019536222A JP2019536222A JP2020503357A5 JP 2020503357 A5 JP2020503357 A5 JP 2020503357A5 JP 2019536222 A JP2019536222 A JP 2019536222A JP 2019536222 A JP2019536222 A JP 2019536222A JP 2020503357 A5 JP2020503357 A5 JP 2020503357A5
Authority
JP
Japan
Prior art keywords
composition according
salt
synthetic
active ingredient
caprilate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019536222A
Other languages
English (en)
Japanese (ja)
Other versions
JP7281815B2 (ja
JP2020503357A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/012261 external-priority patent/WO2018129097A1/en
Publication of JP2020503357A publication Critical patent/JP2020503357A/ja
Publication of JP2020503357A5 publication Critical patent/JP2020503357A5/ja
Priority to JP2023018922A priority Critical patent/JP7466238B2/ja
Application granted granted Critical
Publication of JP7281815B2 publication Critical patent/JP7281815B2/ja
Priority to JP2024047771A priority patent/JP2024075724A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019536222A 2017-01-03 2018-01-03 医薬化合物及び栄養補給剤 Active JP7281815B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023018922A JP7466238B2 (ja) 2017-01-03 2023-02-10 医薬化合物及び栄養補給剤
JP2024047771A JP2024075724A (ja) 2017-01-03 2024-03-25 医薬化合物及び栄養補給剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762441908P 2017-01-03 2017-01-03
US62/441,908 2017-01-03
PCT/US2018/012261 WO2018129097A1 (en) 2017-01-03 2018-01-03 Medicinal compounds and nutritional supplements

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023018922A Division JP7466238B2 (ja) 2017-01-03 2023-02-10 医薬化合物及び栄養補給剤

Publications (3)

Publication Number Publication Date
JP2020503357A JP2020503357A (ja) 2020-01-30
JP2020503357A5 true JP2020503357A5 (US20070167479A1-20070719-C00034.png) 2021-02-12
JP7281815B2 JP7281815B2 (ja) 2023-05-26

Family

ID=62790943

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019536222A Active JP7281815B2 (ja) 2017-01-03 2018-01-03 医薬化合物及び栄養補給剤
JP2023018922A Active JP7466238B2 (ja) 2017-01-03 2023-02-10 医薬化合物及び栄養補給剤
JP2024047771A Pending JP2024075724A (ja) 2017-01-03 2024-03-25 医薬化合物及び栄養補給剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023018922A Active JP7466238B2 (ja) 2017-01-03 2023-02-10 医薬化合物及び栄養補給剤
JP2024047771A Pending JP2024075724A (ja) 2017-01-03 2024-03-25 医薬化合物及び栄養補給剤

Country Status (14)

Country Link
US (2) US20190336472A1 (US20070167479A1-20070719-C00034.png)
EP (1) EP3565539A4 (US20070167479A1-20070719-C00034.png)
JP (3) JP7281815B2 (US20070167479A1-20070719-C00034.png)
KR (1) KR20190103302A (US20070167479A1-20070719-C00034.png)
CN (1) CN110121337A (US20070167479A1-20070719-C00034.png)
AU (2) AU2018206564B2 (US20070167479A1-20070719-C00034.png)
BR (1) BR112019013743A2 (US20070167479A1-20070719-C00034.png)
CA (1) CA3049226A1 (US20070167479A1-20070719-C00034.png)
CL (1) CL2019001832A1 (US20070167479A1-20070719-C00034.png)
CO (1) CO2019008176A2 (US20070167479A1-20070719-C00034.png)
EA (1) EA201991641A1 (US20070167479A1-20070719-C00034.png)
IL (1) IL267831A (US20070167479A1-20070719-C00034.png)
MX (1) MX2019007968A (US20070167479A1-20070719-C00034.png)
WO (1) WO2018129097A1 (US20070167479A1-20070719-C00034.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11180781B2 (en) * 2016-08-21 2021-11-23 Insectergy, Llc Biosynthetic cannabinoid production methods
US10588974B2 (en) 2016-04-22 2020-03-17 Receptor Holdings, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
KR20190103302A (ko) 2017-01-03 2019-09-04 리셉터 홀딩스, 인크. 의약 화합물 및 영양 보충제
US20210052544A1 (en) * 2018-01-29 2021-02-25 Solantech Inc. Methods of treating and/or preventing bedsores using nabilone
MX2021004138A (es) * 2018-10-10 2021-08-05 Tilray Inc Metodos y formulaciones para tratar nauseas y vomito inducidos por quimioterapias.
AR117118A1 (es) * 2018-11-19 2021-07-14 Receptor Holdings Inc Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
US11622956B1 (en) 2019-06-26 2023-04-11 RCR BioPharma Compound and method for treating diseases and disorders
BR112022003555A2 (pt) 2019-08-30 2022-05-24 Sakso Grânulos carregados, seu processo de produção e seus usos
CN113040337B (zh) * 2021-04-22 2022-12-09 四川大学 一种熏肉制品及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1017366A4 (en) 1996-09-01 2006-03-22 Pharmos Corp SOLID COPARCIPITATES FOR IMPROVED BIOVERABILITY OF LIPOPHILIC SUBSTANCES
WO2003045331A2 (en) * 2001-11-29 2003-06-05 Emisphere Technologies, Inc. Formulations for oral administration of cromolyn sodium
WO2008033024A2 (en) 2006-09-15 2008-03-20 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2012069591A1 (en) * 2010-11-25 2012-05-31 Aop Orphan Pharmaceuticals Ag Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
WO2013032934A1 (en) * 2011-08-26 2013-03-07 Aegis Therapeutics, Llc Compositions and methods thereof for oral administration of drugs
CA2845443A1 (en) * 2014-03-04 2015-09-04 Pharmascience Inc. Orally disintegrating tablet of nabilone and method of manufacturing
US10588974B2 (en) * 2016-04-22 2020-03-17 Receptor Holdings, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
KR20190103302A (ko) 2017-01-03 2019-09-04 리셉터 홀딩스, 인크. 의약 화합물 및 영양 보충제

Similar Documents

Publication Publication Date Title
JP2020503357A5 (US20070167479A1-20070719-C00034.png)
JP2022031762A5 (US20070167479A1-20070719-C00034.png)
ECSP067111A (es) Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica
EA201291348A1 (ru) Активаторы растворимой гуанилатциклазы
BRPI0813044A2 (pt) "composto, composição fungicida e método para o controle do fungo fitopatogênico de culturas"
SG10201804024VA (en) Formulations of azaindole compounds
EA201070841A1 (ru) НОВЫЕ ПИРАЗОЛО[3,4-d]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПРОТИВОРАКОВЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ
JP2016540809A5 (US20070167479A1-20070719-C00034.png)
MX2019006165A (es) Proceso para la preparacion de derivados del acido biliar de las sulfonilureas.
HRP20120478T1 (hr) Formulacije koje sadrže spojeve srodne jorumicinu renieramicinu safracinu ili saframicinu i disaharid za liječenje proliferativnih oboljenja
WO2009007137A3 (en) Pharmaceutical composition for topical application of poorly soluble compounds
JP2013518036A5 (US20070167479A1-20070719-C00034.png)
RU2010110603A (ru) Высококонцентрированные препараты 1-метилгептилового эфира флуроксипира, стабильные при низких температурах
CL2019002677A1 (es) Composición adhesiva y método de preparación de la misma.
RU2014116395A (ru) Соединения, композиции и способы для снижения или устранения горького вкуса
HRP20160802T1 (hr) Čvrsti farmaceutski pripravci koji sadrže derivate biopterina i upotreba takvih pripravaka
AR069225A1 (es) Procedimiento de preparacion de compuestos morfinicos
JP2019526634A5 (US20070167479A1-20070719-C00034.png)
HRP20190783T1 (hr) Farmaceutske formulacije
RU2018117499A (ru) Производные 6-[5-амино-6-(2-этоксиэтокси)-имидазо[4,5-b]пиридин-3-ил]никотинонитрила и их применение в качестве irak ингибиторов
AR063467A1 (es) Preparacion de sales farmaceuticas del acido 3-o-(3',3'-dimetilsuccinil)betulinico; sales del mismo, composiciones farmaceuticas que las comprenden y el empleo de estas en el tratamiento de infecciones con vih.
JP2008524259A5 (US20070167479A1-20070719-C00034.png)
CN1203600A (zh) 二氨基嘧啶,含它们的药物组合物和其作为抗菌药物的用途
EA202190036A1 (ru) Кристаллическая форма соединения для ингибирования активности cdk4/6 и ее применение
BRPI0411402A (pt) derivados de fenil-5, 7-di-hidrocarbil-3, 7di-hidropirrolo [2,3-d] pirimidin-4-ona 2-substituìda, sua preparação e seu uso farmacêutico